Evidence map›Paper›PMID 26418280›Full record

ArticleCell adhesion & migration2016

Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells.

Stefan Hutter, Diana M Morales-Prieto, Ulrich Andergassen, Lisa Tschakert, Christina Kuhn, Simone Hofmann, Udo R Markert, Udo Jeschke

Open access · goldAbstract read
In one paragraph

Article in Cell adhesion & migration, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Gal-2 Increases H3K4meBiomolecules · 2022
    Article
  7. Galectins in Early Pregnancy and Pregnancy-Associated Pathologies.International journal of molecular sciences · 2021
    Review
  8. Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  9. Article
  10. Review
  11. Article
  12. [The involvement of galectin-1 in implantation and pregnancy maintenance at the maternal-fetal interface].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Stefan Huttera Ludwig Maximilians University of Munich , Department of Obstetrics and Gynecology , Munich , Germany.
Diana M Morales-Prietob University Hospital Jena , Department of Obstetrics , Placenta Lab , Jena , Germany.
Ulrich Andergassena Ludwig Maximilians University of Munich , Department of Obstetrics and Gynecology , Munich , Germany.
Lisa Tschakerta Ludwig Maximilians University of Munich , Department of Obstetrics and Gynecology , Munich , Germany.
Christina Kuhna Ludwig Maximilians University of Munich , Department of Obstetrics and Gynecology , Munich , Germany.
Simone Hofmanna Ludwig Maximilians University of Munich , Department of Obstetrics and Gynecology , Munich , Germany.
Udo R Markertb University Hospital Jena , Department of Obstetrics , Placenta Lab , Jena , Germany.
Udo Jeschkea Ludwig Maximilians University of Munich , Department of Obstetrics and Gynecology , Munich , Germany.
Ludwig-Maximilians-Universität München · DEJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galectin-1 (gal-1), a member of the mammalian β-galactoside-binding proteins, exerts biological effects by recognition of glycan ligands, including those involved in cell adhesion and growth regulation. In previous studies, we demonstrated that gal-1 induces cell differentiation processes on the membrane of choriocarcinoma cells BeWo, including the receptor tyrosine kinases (RTKs) REarranged during Transfection (RET), Janus Kinase 2 (JAK2) and Vascular endothelial growth factor receptor 3 (VEGFR3). Furthermore, Mitogen-Activated Protein Kinases (MAPK) and serine/threonine kinases were phosphorylated by gal-1. In addition, gal-1 in trophoblast cells in vitro induced syncytium formation especially after concentration dependent stimulation of the cells with this galectin. This is in contrast to MAPK-inhibitor U0126 that reduced syncytium formation of BeWo cells. The aim of this study was to analyze the syncytium formation abilities of BeWo cells that were gal-1 silenced. We found a significantly reduced syncytium formation rate in gal-1 silenced BeWo cells. In addition, these cells show a different miRNA expression profile. In summary, we found that gal-1 is a major trigger for fusion processes in BeWo cells. This function is accompanied by different regulation of miRNA synthesis in the BeWo cell culture model.

Indexed as

Gene Silencingbeta CateninCadherinsCell FusionCell Line, TumorEnzyme-Linked Immunosorbent AssayFemaleFluorescent Antibody TechniqueGalectin 1Gene Expression Regulation, NeoplasticGiant CellsHumansImmunohistochemistryMicroRNAsReal-Time Polymerase Chain ReactionRNA, Messengerbeta CateninCadherinsGalectin 1MicroRNAsRNA, MessengerBeWogalectin-1miRNAsyncytium formation

Identifiers

PMID26418280
PMCPMC4853045
OpenAlexW2318621724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.